Catalyst Wire Dossier Catalyst Wire Dossier

NAFT900

· Merz North America, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NAFT900, covering 2016-09-09 to 2016-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of NAFT900 in Children With Tinea Capitis [Phase 2]

See pricing